Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001971857-24-000863
Filing Date
2024-12-16
Accepted
2024-12-16 16:21:34
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4034
  Complete submission text file 0001971857-24-000863.txt   5421
Mailing Address 2150 WOODWARD ST., SUITE 100 AUSTIN TX 78744
Business Address
O'Neill Vincent (Reporting) CIK: 0001672718 (see all company filings)

Type: 144

Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Subject) CIK: 0001720893 (see all company filings)

EIN.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-38410 | Film No.: 241552126
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)